News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,219 Results
Type
Article (64418)
Company Profile (183)
Press Release (680618)
Multimedia
Podcasts (112)
Webinars (13)
Section
Business (208220)
Career Advice (3108)
Deals (36183)
Drug Delivery (115)
Drug Development (83502)
Employer Resources (177)
FDA (16914)
Job Trends (15768)
News (355249)
Policy (34591)
Tag
Academia (2906)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (93)
Alliances (52983)
ALS (96)
Alzheimer's disease (1426)
Antibody-drug conjugate (ADC) (140)
Approvals (16909)
Artificial intelligence (296)
Autoimmune disease (23)
Automation (16)
Bankruptcy (336)
Best Places to Work (12146)
BIOSECURE Act (21)
Biosimilars (113)
Biotechnology (123)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (289)
Cancer (2338)
Cardiovascular disease (183)
Career advice (2634)
Career pathing (34)
CAR-T (164)
Cell therapy (463)
Cervical cancer (21)
Clinical research (67549)
Collaboration (873)
Compensation (428)
Complete response letters (23)
COVID-19 (2767)
CRISPR (46)
C-suite (263)
Cystic fibrosis (105)
Data (2233)
Decentralized trials (2)
Denatured (40)
Depression (44)
Diabetes (273)
Diagnostics (6752)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (133)
Drug pricing (112)
Drug shortages (29)
Duchenne muscular dystrophy (93)
Earnings (80731)
Editorial (42)
Employer branding (21)
Employer resources (154)
Events (114999)
Executive appointments (769)
FDA (18215)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (777)
Gene editing (116)
Generative AI (31)
Gene therapy (328)
GLP-1 (756)
Government (4925)
Grass and pollen (6)
Guidances (57)
Healthcare (20094)
Huntington's disease (19)
IgA nephropathy (29)
Immunology and inflammation (128)
Indications (30)
Infectious disease (2912)
Inflammatory bowel disease (146)
Inflation Reduction Act (10)
Influenza (55)
Intellectual property (100)
Interviews (588)
IPO (16487)
IRA (44)
Job creations (4064)
Job search strategy (2197)
Kidney cancer (10)
Labor market (34)
Layoffs (528)
Leadership (24)
Legal (8336)
Liver cancer (79)
Lung cancer (329)
Lymphoma (154)
Machine learning (7)
Management (61)
Manufacturing (318)
MASH (68)
Medical device (14272)
Medtech (14277)
Mergers & acquisitions (20280)
Metabolic disorders (706)
Multiple sclerosis (82)
NASH (20)
Neurodegenerative disease (96)
Neuropsychiatric disorders (27)
Neuroscience (1978)
NextGen: Class of 2025 (7158)
Non-profit (4933)
Now hiring (23)
Obesity (368)
Opinion (265)
Ovarian cancer (75)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (22)
Patents (247)
Patient recruitment (114)
Peanut (51)
People (62195)
Pharmaceutical (41)
Pharmacy benefit managers (17)
Phase I (21073)
Phase II (29601)
Phase III (22075)
Pipeline (1193)
Policy (151)
Postmarket research (2874)
Preclinical (9224)
Press Release (70)
Prostate cancer (112)
Psychedelics (34)
Radiopharmaceuticals (267)
Rare diseases (396)
Real estate (6601)
Recruiting (70)
Regulatory (23535)
Reports (40)
Research institute (2588)
Resumes & cover letters (473)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (138)
Series B (89)
Service/supplier (14)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (156)
Sponsored (33)
Startups (3792)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (34)
The Weekly (70)
Vaccines (752)
Venture capitalists (40)
Weight loss (251)
Women's health (35)
Worklife (20)
Date
Today (174)
Last 7 days (889)
Last 30 days (2714)
Last 365 days (33452)
2025 (10978)
2024 (35730)
2023 (40445)
2022 (51676)
2021 (56690)
2020 (55769)
2019 (49680)
2018 (37825)
2017 (34545)
2016 (34623)
2015 (40508)
2014 (34109)
2013 (30308)
2012 (31976)
2011 (31934)
2010 (30641)
Location
Africa (1029)
Alabama (58)
Alaska (7)
Arizona (223)
Arkansas (14)
Asia (44052)
Australia (7749)
California (6002)
Canada (2006)
China (547)
Colorado (276)
Connecticut (289)
Delaware (151)
Europe (100366)
Florida (905)
Georgia (215)
Idaho (61)
Illinois (580)
India (29)
Indiana (312)
Iowa (9)
Japan (166)
Kansas (108)
Kentucky (25)
Louisiana (11)
Maine (64)
Maryland (916)
Massachusetts (4521)
Michigan (239)
Minnesota (407)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (24)
Nevada (63)
New Hampshire (70)
New Jersey (1749)
New Mexico (30)
New York (1750)
North Carolina (1026)
North Dakota (8)
Northern California (2626)
Ohio (202)
Oklahoma (15)
Oregon (36)
Pennsylvania (1336)
Puerto Rico (12)
Rhode Island (30)
South America (1372)
South Carolina (23)
South Dakota (1)
Southern California (2257)
Tennessee (103)
Texas (901)
United States (23204)
Utah (189)
Virginia (145)
Washington D.C. (61)
Washington State (568)
West Virginia (3)
Wisconsin (60)
745,219 Results for "national institute of standards and technology nist".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Mission Bio Announces High Precision Detection of Variants For Tapestri® Platform in NIST Genome Editing Consortium Initial Study
Mission Bio announced today initial results from the National Institute of Standards and Technology (NIST) Genome Editing Consortium’s inaugural Interlab Study.
October 23, 2023
·
4 min read
Bio NC
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
BioSkryb Genomics today announced it has joined the NIST Genome Editing Consortium to help address the measurements and standards needed to increase confidence of utilizing genome editing technologies in research and commercial products.
September 13, 2023
·
3 min read
The US National Institute of Standards and Technology (NIST) has evaluated the use of Genomic Vision applications for genetic variant characterization
Bagneux – Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, is pleased to announce the successful evaluation of its DNA combing technology by the US National Institute of Standards and Technology.
February 21, 2023
·
5 min read
Press Releases
ChromaTan and Landmark Bio Awarded National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Grant to Advance Intensified Recombinant Adeno-Associated Virus (AAV) Production Process
March 18, 2025
·
4 min read
Biotech Bay
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
Twist Bioscience Corporation today announced that the company has joined the U.S. AI Safety Institute Consortium (AISIC), a group established by the Department of Commerce’s National Institute of Standards and Technology (NIST) to support the development and deployment of trustworthy and safe AI.
June 4, 2024
·
5 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Press Releases
New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests
April 10, 2025
·
5 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
1 of 74,522
Next
